Arash Vahdat

Jan 13, 2025 | developer.nvidia.com | Kyle Tretina |Seul Lee |Weili Nie |Arash Vahdat

Traditional computational drug discovery relies almost exclusively on highly task-specific computational models for hit identification and lead optimization. Adapting these specialized models to new tasks requires substantial time, computational power, and expertise—challenges that grow when researchers simultaneously work across multiple targets or properties.